Product Launch

Shanghai – September 20, 2026 -- Huawei unveiled a new immersive telepresence system at HUAWEI CONNECT 2026, targeting enterprise remote collaboration with upgraded audiovisual hardware and an expanded open developer ecosystem.

New CloudLink Camera 610 eliminates visual seams in panoramic conferencing

The HUAWEI CloudLink Camera 610 AI panoramic fusion camera uses a multimodal optical flow splicing algorithm to produce distortion-free, seamless digital panoramic imagery and 1:1 lifelike representations of meeting participants. The system pairs this with an omnidirectional independent stereo sound pickup unit featuring AI-based noise separation and a multi-channel stereo speaker array for high-fidelity playback with sound localization.

Hoboken, N.J. – September 20, 2026 -- Quantum Computing Inc. (Nasdaq: QUBT) will demonstrate, for the first time, a platform combining quantum key distribution (QKD) with hardware-based Quantum Identity Authentication (QIA) on a single system at ECOC Exhibition 2026, running September 21-23 at FYCMA in Málaga, Spain.

QCi merges encryption and authentication into one telecom-compatible architecture

At Booth #1436, the company will showcase high-dimensional QKD, direct entanglement verification, QIA and integrated key management combined in a single platform. Traditional QKD systems have faced barriers including scalability limits, operational complexity, high infrastructure costs and reliance on classical authentication methods, confining much of the technology to research settings rather than commercial deployment.

Columbus, Ohio – September 20, 2026 -- Andelyn Biosciences has begun commercial manufacturing of FAYUVI (rebisufligene etisparvovec-hopf) at its Columbus facility, marking the first FDA-approved gene therapy produced using the company's AAV Curator Platform process. The therapy, developed by Ultragenyx Pharmaceutical Inc., recently received U.S. Food and Drug Administration approval for treating Sanfilippo syndrome type A, also known as mucopolysaccharidosis type IIIA (MPS IIIA).

FDA clears gene therapy for a rare, fatal childhood disease

MPS IIIA is a rare lysosomal storage disorder that drives rapid neurodegeneration starting in early childhood, primarily affecting the central nervous system. The disease impacts an estimated 3,000 to 5,000 patients worldwide, with a median life expectancy of 15 years.

Qingdao – September 19, 2026 -- Qingdao SOCO New Material Co., Ltd. has launched ODORSORB-101, a plant-based liquid formulated to chemically capture nitrogen- and sulfur-based odor compounds at industrial and municipal sites rather than mask them.

Product targets ammonia, sulfide and amine compounds at the source

ODORSORB-101 is engineered to capture and lock odor-causing molecules including ammonia, methylamine, trimethylamine, hydrogen sulfide, mercaptans and sulfides, reducing their volatility and limiting re-release into surrounding air. These compounds are commonly generated at wastewater plants, sludge and leachate ponds, manure storage and organic waste sites.

Sarasota – September 19, 2026 -- Chicken Salad Chick will open its third Southwest Florida restaurant on September 29 at 6650 Fruitville Road in the Fruitville Farms shopping center, marking the brand's first location in Sarasota County.

First 100 guests in line win free chicken salad for a year

The chain's grand-opening giveaway offers the first guest in line at 10:30 a.m. one free large Quick Chick portion weekly for a year, while guests two through 100 receive the same portion monthly for a year. Additional daily promotions through October 3 include free Tervis Tumblers, grocery totes and Chick Coolers for the first 50 guests each day who purchase a two-side meal or equivalent.

Shanghai – September 19, 2026 -- Carestream Healthcare International has launched the STARVIEW Digital Radiography System, a floor-mounted DR room built for routine radiographic imaging.

STARVIEW targets facilities upgrading from film, CR or aging DR systems

The system is designed to serve healthcare facilities introducing a first DR room, replacing legacy film-based or computed radiography equipment, or expanding routine-imaging capacity. Carestream built the platform around three pillars: fully digital operation, ease of adoption and scalability for future growth.

Madrid – September 19, 2026 -- mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed emicizumab biosimilar targeting hemophilia A, a treatment referencing Roche's Hemlibra with an estimated global reference market of USD 5.7 billion.

mAbxience will develop and manufacture the biosimilar at GMP facilities in Spain and Argentina

Under the agreement, mAbxience is responsible for development and manufacturing through its facilities in the two countries. Sandoz will handle global commercialization.

Sandoz secures exclusive global rights excluding three South American markets

Sandoz holds exclusive commercialization rights worldwide, with the exception of Argentina, Uruguay and Paraguay. Financial terms of the deal were not disclosed.

Helsinki – September 19, 2026 -- Scailarc, Nokia and Elisa have completed a proof-of-concept demonstrating a first-of-its-kind mobile calling scenario in which a customer completes a service task without ever answering the call, using IMS Data Channel technology and Nokia's Network as Code platform for trusted caller verification.

Customer books fibre installation via visual screen while call rings unanswered

In the demo, Elisa calls a customer about a fibre installation. Unable to speak, the customer views a trusted interactive call screen and selects "Book installation time." Elisa's system registers the customer moving to self-service, and the task is completed immediately without the call being picked up. The call was placed using the new Jolla Phone.

New Delhi – September 19, 2026 -- Apollo Athenaa Women's Cancer Centre has treated more than 30,000 women from over 110 cities and performed 1,000-plus cancer surgeries in its first year of operation, marking its anniversary as Asia's first dedicated cancer centre for women.

Centre completes 4,000+ chemotherapy cycles and 100+ reconstruction procedures in year one

Apollo Athenaa's clinical volumes in its debut year include over 4,000 chemotherapy cycles, more than 100 plastic and breast reconstruction procedures, and 120-plus VABB (vacuum-assisted breast biopsy) procedures. The centre built an integrated care model spanning breast and gynaecological oncology, reconstruction, medical and precision oncology, diagnostics and rehabilitation.

Los Angeles – September 19, 2026 -- PolyGone Systems has developed a biomimetic filtration media that captures up to 98% of microplastic particles down to the nanoscale, using a gravity-driven, low-energy process designed to fit into existing municipal and industrial water treatment infrastructure.

PolyGone rejects size-restrictive filtration in favor of material-affinity capture

Rather than relying on mechanical barriers that filter by particle size and are prone to clogging, PolyGone's system uses materials engineered to naturally attract and isolate microscopic plastic fragments. The company states this approach allows treatment operators to remove contaminants without the high energy costs or operational disruption associated with conventional fine-filtration equipment.